Takashi Satou

2011 update<scp>J</scp>apanese<scp>S</scp>ociety for<scp>D</scp>ialysis<scp>T</scp>herapy Guidelines of Vascular Access Construction and Repair for Chronic Hemodialysis

Kazutaka Kukita, Seiji Ohira, Izumi Amano et al. · Therapeutic Apheresis and Dialysis · 2015 · 209 citations · Full text

Medicine, Nephrology, Surgery +17

Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group

Toshie Mashiba, Kouji Joko, Masayuki Kurosaki et al. · PLoS ONE · 2018 · 56 citations · Full text

Medicine, Oncology, Cancer Control +16

Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase Inhibitor

Pamela Farrell, Lihong Shi, Jennifer Matuszkiewicz et al. · Molecular Cancer Therapeutics · 2013 · 45 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure

Jun Itakura, Masayuki Kurosaki, Chitomi Hasebe et al. · PLoS ONE · 2016 · 38 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Real‐world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group

Toshie Mashiba, Kouji Joko, Masayuki Kurosaki et al. · Hepatology Research · 2019 · 23 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16